Antithrombin III deficiency: Difference between revisions
Jump to navigation
Jump to search
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Name = {{PAGENAME}} | | Name = {{PAGENAME}} | | ||
Line 13: | Line 12: | ||
MeshID = D020152 | | MeshID = D020152 | | ||
}} | }} | ||
'''For patient information click [[Antithrombin III deficiency (patient information)|here]]''' | |||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Line 27: | Line 25: | ||
In [[renal failure]], especially [[nephrotic syndrome]], antithrombin is lost in the urine, leading to a higher activity of [[Factor II]] and [[Factor X]] and in increased tendency to [[thrombosis]]. | In [[renal failure]], especially [[nephrotic syndrome]], antithrombin is lost in the urine, leading to a higher activity of [[Factor II]] and [[Factor X]] and in increased tendency to [[thrombosis]]. | ||
== | ==Related Chapters== | ||
* [[Antithrombin]] | * [[Antithrombin]] | ||
Revision as of 13:01, 21 September 2012
Antithrombin III deficiency | |
ICD-9 | 289.81 |
---|---|
OMIM | 107300 |
DiseasesDB | 783 |
MeSH | D020152 |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Antithrombin III deficiency is a rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism.
This was first described by Egeberg in 1965.[1]
The patients are treated with anticoagulants or, more rarely, with antithrombin concentrate.
In renal failure, especially nephrotic syndrome, antithrombin is lost in the urine, leading to a higher activity of Factor II and Factor X and in increased tendency to thrombosis.
Related Chapters
References
- ↑ Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965;13:516–520. PMID 14347873.